Pascal and Francis Bibliographic Databases

Help

Search results

Your search

ti.\*:("Immunotherapeutics")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 369

  • Page / 15
Export

Selection :

  • and

Modulating tone : the overture of S1P receptor immunotherapeuticsROSEN, Hugh; GONZALEZ-CABRERA, Pedro; MARSOLAIS, David et al.Immunological reviews. 2008, Vol 223, pp 221-235, issn 0105-2896, 15 p.Article

ImmunotherapeuticsCHAN, Andrew C.Immunological reviews. 2008, Vol 223, issn 0105-2896, 420 p.Serial Issue

Investigational Immunotherapeutics for B-Cell MalignanciesQUINTAS-CARDAMA, Alfonso; WIERDA, William; O'BRIEN, Susan et al.Journal of clinical oncology. 2010, Vol 28, Num 5, pp 884-892, issn 0732-183X, 9 p.Article

Therapeutic targeting of Janus kinasesPESU, Marko; LAURENCE, Arian; KISHORE, Nandini et al.Immunological reviews. 2008, Vol 223, pp 132-142, issn 0105-2896, 11 p.Article

HLA-derived peptides as novel immunotherapeuticsKRENSKY, A. M; CLAYBERGER, C.Clinical immunology and immunopathology (Print). 1995, Vol 75, Num 2, pp 112-116, issn 0090-1229Article

Biologics and postbiologics: novel Immunotherapeutics for the induction and maintenance of remissionVAN EDEN, Willem; LISSE, Jeffrey; PRAKKEN, Berent et al.Drug discovery today. 2010, Vol 15, Num 1-2, pp 71-77, issn 1359-6446, 7 p.Article

Integrin-associated proteins as potential therapeutic targetsCANTOR, Joseph M; GINSBERG, Mark H; RESET, David M et al.Immunological reviews. 2008, Vol 223, pp 236-251, issn 0105-2896, 16 p.Article

Th 17 cells in human diseaseTESMER, Laura A; LUNDY, Steven K; SARKAR, Sujata et al.Immunological reviews. 2008, Vol 223, pp 87-113, issn 0105-2896, 27 p.Article

Targeting lymphocyte activation through the lymphotoxin and LIGHT pathwaysWARE, Carl F.Immunological reviews. 2008, Vol 223, pp 186-201, issn 0105-2896, 16 p.Article

B-lymphocyte contributions to human autoimmune diseaseYANABA, Koichi; BOUAZIZ, Jean-David; MATSUSHITA, Takashi et al.Immunological reviews. 2008, Vol 223, pp 284-299, issn 0105-2896, 16 p.Article

Strategies for use of IL-10 or its antagonists in human diseaseO'GARRA, Anne; BARRAT, Franck J; CASTRO, Antonio G et al.Immunological reviews. 2008, Vol 223, pp 114-131, issn 0105-2896, 18 p.Article

Development of TLR inhibitors for the treatment of autoimmune diseasesBARRAT, Franck J; COFFMAN, Robert L.Immunological reviews. 2008, Vol 223, pp 271-283, issn 0105-2896, 13 p.Article

HIV immunotherapeutic vaccinesPETERS, Barry S.Antiviral chemistry & chemotherapy. 2000, Vol 11, Num 5, pp 311-320, issn 0956-3202Article

The immunotherapeutic potential of the monocyteWILLIAMS, M. A; NEWLAND, A. C; KELSEY, S. M et al.The Cancer journal (Print). 1998, Vol 11, Num 3, pp 111-126, issn 0765-7846Article

The basis for HIV immunotherapeutic vaccinesPETERS, B. S.Vaccine. 2001, Vol 20, Num 5-6, pp 688-705, issn 0264-410XArticle

DNA-based immunotherapeutics for the treatment of allergic diseaseHORNER, Anthony A; VAN UDEN, John H; ZUBELDIA, Jose M et al.Immunological reviews. 2001, Vol 179, pp 102-118, issn 0105-2896Article

IMMUNOTHERAPEUTIC TREATMENT OF CONDYLOMA ACUMINATAABLIN RJ; CURTIS WW.1974; GYNECOL. ONCOL.; U.S.A.; DA. 1974; VOL. 2; NO 4; PP. 446-450; BIBL. 9REF.Article

Immunotoxicity of immunotherapeutic agentsJOHNSON, A. G; REGAL, J.Springer seminars in immunopathology. 1985, Vol 8, Num 4, pp 347-359, issn 0344-4325Article

IL-1, IL-18, and IL-33 families of cytokinesAREND, William P; PALMER, Gaby; GABAY, Cem et al.Immunological reviews. 2008, Vol 223, pp 20-38, issn 0105-2896, 19 p.Article

BAFF blockade for systemic lupus erythematosus : will the promise be fulfilled?RAMANUJAM, Meera; DAVIDSON, Anne.Immunological reviews. 2008, Vol 223, pp 156-174, issn 0105-2896, 19 p.Article

The spectrum of complement alternative pathway-mediated diseasesHOLERS, V. Michael.Immunological reviews. 2008, Vol 223, pp 300-316, issn 0105-2896, 17 p.Article

Radioimmunoscintigraphy using 111In-labeled monoclonal antibodies and the case for immunotherapeuticsHALPERN, S. E; HAGAN, P; WITZTUM, K. F et al.Journal of medical technology. 1985, Vol 2, Num 5, pp 301-305, issn 0741-5397Article

Focal adhesion kinase as an immunotherapeutic targetKOBAYASHI, Hiroya; AZUMI, Makoto; KIMURA, Yuka et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 6, pp 931-940, issn 0340-7004, 10 p.Article

Immunotherapeutic potential of whole tumour cellsWARD, Stephen; CASEY, David; LABARTHE, Marie-Christine et al.Cancer immunology and immunotherapy. 2002, Vol 51, Num 7, pp 351-357, issn 0340-7004Article

Immunotherapeutic potential of antibodies produced in plantsMA, J. K.-C; HEIN, M. B.Trends in biotechnology (Regular ed.). 1995, Vol 13, Num 12, pp 522-527, issn 0167-7799Article

  • Page / 15